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Liver microsomes contain a mixed function oxidase system capable of metabo- 
lizing a broad range of biologically active substances, including drugs, steroids, 
and environmental chemicals such as polycyclic hydrocarbons. 
Certain hemoproteins, collectively referred to as cytochrome P-450, function 
as the terminal oxidase in this system. The fact that this hepatic mixed function 
oxidase system is sensitive to induction and inhibition by many of its substrates 
and other agents has provided an approach to understanding a major mecha- 
nism by which endogenously- and environmentally-derived  substances may af- 
fect each otheFs disposition and biological impact (1). 
Mixed  function oxidase  activities  which depend on  cytochrome P-450 are 
present in many tissues other than liver, including such endocrine organs as 
adrenal, testes, and placenta, such sites of direct xenobiotic exposure as lung, 
intestine, and skin,  and such sites of drug action as heart and kidney. Cyto- 
chrome P-450 has also been detected in each of these tissues. Aryl hydrocarbon 
hydroxylase (AHH) is an example of a mixed function oxidase involving cyto- 
chrome P-450 whose  distribution  and  properties  have  been  widely studied. 
Benzo[a]pyrene (BP),  which is a  carcinogenic constituent of cigarette smoke 
and charcoal-broiled meat, is both a substrate and an inducer of this enzyme 
activity. 
Because many of the substrates of the hepatic cytochrome P-450 system have 
major actions on the central nervous system, this study was undertaken to 
determine whether this cytochrome, and the related AHH activity, could be 
detected in brain. 
Materials and Methods 
Microsomes were prepared from rat brains as follows: male,  Sprague-Dawley,  125-150-g rats 
were decapitated and the brains were immediately removed and transferred to cold saline. Large 
blood vessels and clots were  excised and the pooled brains were  homogenized in 4  vol of KC1 
(1.15%),  by using a  glass Teflon homogenizer.  This homogenate was centrifuged for 20 min at 
ll,000g; the supernate was then centrifuged for 60 min at 105,000g; the resulting microsome pellet 
was washed in KC1 and then suspended in buffer (0.1 M potassium phosphate, pH 7.4). 
AHH  activity was  determined by using BP  as  the substrate by the method  of Nebert and 
Gelboin (2), as modified by Alvares et al. (3). Brain microsomal suspensions were incubated for 30 
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min at 37°C in 1.05 ml buffer containing  100 nmol BP, 1 ~mol NADPH, 3 ~mol MgC12, and 1 mg 
bovine serum albumin. In other experiments, homogenate equivalent to 100 mg brain wet weight 
was also incubated as above,  except that albumin was omitted.  The reaction was stopped by 
adding  1 ml cold  acetone,  either  before  (for  blank determinations)  or  after incubation.  BP 
metabolites were then extracted from the mixture, first into hexane, and then into 1 N NaOH, in 
which the concentration  of hydroxylated (OH-) BP was determined by measuring the fluorescence 
at 522 nm during excitation at 396 nm. Hydroxy-BP standards were prepared by adding genuine 8- 
OH-BP instead of BP to incubation  mixtures and extracting as for blank determinations. The 
activation and fluorescence spectra of the extracted metabolites after incubation of brain micro- 
somes or homogenates with BP, and the spectra of 8-OH-BP, added to and immediately extracted 
from unincubated mixtures, were identical. 
Protein was determined by using bovine serum albumin as the standard (4). 
The carbon monoxide (CO) complex of reduced cytochrome P-450 strongly adsorbs light at 450 
nm. Because both the reduced cytochrome, alone, and the CO-complex of the oxidized cytochrome 
do  not  strongly  absorb light  of this  wavelength,  difference  spectra  permit detection  of the 
cytochrome in turbid suspensions  (5-7). 
Results  and  Discussion 
In Fig.  1 A,  the  difference spectrum between the  CO-complex of dithionite- 
reduced brain  microsomes and  the  CO-complex of oxidized  microsomes is  de- 
picted.  The  absorbance  maximum  (425  nm)  and  minimum  (408  nm)  in  this 
spectrum correspond to the oxidized-minus-reduced spectrum of cytochrome bs, 
which has been previously detected in brain microsomes (8). Cytochrome b5 does 
not  bind  CO.  However,  the  deflection  in  absorbance  near  450  nm  is  only 
pronounced in the  presence of CO,  as in Fig.  1 A,  and  is  not characteristic  of 
cytochrome bs. The effect of NADH on the dithionite-difference spectrum of CO- 
bound brain  microsomes supports  the  idea that this  deflection is due  to cyto- 
chrome P-450.  NADH transfers its reducing equivalents directly to cytechrome 
b5 via the flavoprotein, cytochrome b5 reductase (E.C.  1.6.2.2.),  which has been 
detected in brain microsomes (8).  Cytochrome P-450 differs from cytochrome b5 
in that it cannot be directly reduced by NADH aerobically (5).  For this reason, 
the  addition  of NADH to both the  sample and reference  cuvettes which  were 
compared in Fig.  1 A  should result in a  diminished contribution to the absorb- 
ance difference by cytochrome b5 (which would become reduced in the reference 
as well as the sample cuvette), and an unaffected contribution by cytochrome P- 
450 (which would remain oxidized in the reference cuvette). Fig.  1 B depicts the 
difference spectrum after adding NADH to the cuvettes compared in Fig. 1 A. As 
expected,  the  addition  of  NADH  resulted  in  a  difference  spectrum  with  a 
diminished minimum at 408 nm and a diminished maximum at 425 nm, yielding 
resolution of the absorbance at 450 nm as a  distinct peak. A  spectrum indistin- 
guishable  from that  in  Fig.  1 B  was  obtained  either  when  more  NADH  was 
added  (to  a  final  concentration  of 1  mM)  or  when  NADH  was  added  to  the 
microsomes before exposure to CO, adjustment of the base line, and addition of 
dithionite to the sample cuvette only. 
The CO-difference spectrum of dithionite-reduced brain microsomes provided 
direct evidence that cytochrome P-450 was present in these suspensions.  Such a 
spectrum is presented in Fig. 2 A. The absorbance maximum at 454 nm reflects 
the absorbance difference between the CO-complex of reduced cytochrome P-450 
and the reduced cytochrome, alone.  The other absorbance maximum  (420 nm) 
and the minimum (438 nm) in this spectrum may be due to cytochrome P-420 or COHN  ET  AL. 
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Fro.  1.  The  effect of NADH  on  the dithionite-difference spectrum of CO-bound brain 
microsomes. Microsomes (0.7  mg protein in 0.4 ml) were added to both cuvettes, CO was 
bubbled in each, and the base line was adjusted. A.  Dithionite and more CO were then 
added to the sample only and the difference spectrum recorded after 3 rain. B. 25 ~l NADH 
(5 mg/ml buffer) and more CO were then added to both cuvettes and the difference spectrum 
was recorded after 5 min. 
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Fzo.  2.  The effect of mercury on the CO-difference  spectrum of  reduced brain microsomes. 
Microsomes were mixed with dithionite and added to each cuvette. A. The base line was 
adjusted, CO was added to the sample only, and the difference spectrum was recorded. B. 25 
~1 mercury (4 mg/ml methylmercury chloride in 1.15% KC1) was then added to each cuvette 
and the difference spectrum was again recorded after 2 min. 
hemoglobin. When examined by this method, the absorbance peak of placental 
cytochrome P-450 is also at 454 nm, instead of precisely 450 nm (6). 
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chrome P-450 is quantitatively degraded in vitro to its inactive form, cytochrome 
P-420, by methylmercury. To confirm that brain microsomes contain a chromo- 
phore which is susceptible to such degradation, 0.4 ~mol mercury as methylmer- 
cury chloride was added to each of the cuvettes compared in Fig. 2 A, and the 
difference  spectrum  was  again  recorded.  During  the  next  few minutes,  the 
absorbance maximum near 450 nm gradually diminished,  and the extrema at 
420  and  438 nm  correspondingly  increased  in magnitude.  2 min after adding 
mercury, these changes were pronounced, as shown in Fig. 2 B. These changes 
in the CO difference spectrum of reduced brain microsomes are precisely those 
which were observed when hepatic microsomes were similarly treated (9),  and 
document the  simultanaous  loss  of one  cytochrome  (P-450)  and  formation  of 
another  (P-420).  This  formation  of cytochrome  P-420  from  brain  microsomes 
exposed to mercury is clear evidence that these microsomes originally contained 
cytochrome P-450. 
An  independent  approach  to  the  question  of whether  brain  contains  cyto- 
chrome P-450 is to examine the ability of this organ to metabolize substances 
which are substrates of the cytochrome in other tissues.  BP was selected as a 
model substrate because its hydroxylated metabolites are intensely fluorescent. 
We have found that brain microsomes do metabolize BP at a  rate sufficient to 
produce appreciable fluorescence: incubation of 2 mg microsomal protein for 30 
min resulted in about five times the fluorescence of blank determinations, which 
is equivalent to the formation  of about 30 pmol OH-BP/mg protein per h.  As 
controls, mixtures from which NADPH or microsomes were omitted, or which 
were incubated at 0°C produced no net fluorescence, relative to blank determi- 
nations. 
In other experiments, this activity was detected at a lower specific activity in 
brain homogenates. By using this enzyme source, brain AHH was estimated in 
individual rats and the effect of pretreatment with an inducer of hepatic AHH, 
3-methylcholanthrene  (3-MC), was studied. Five rats were injected intraperito- 
neally with 3-MC (25 mg/kg/d) for 6 days before sacrifice. The mean (_+ standard 
deviation) brain homogenate AHH activity in these 3-MC-pretreated rats was 25 
±  2 pmol OH-BP formed/mg protein per h. This is a four-fold increase over the 
activity  in  five  untreated  rats  (5  ±  1 pmol  OH-BP/mg  protein  per  h);  this 
increase is statistically significant  (P <  0.001) with Student's t test. 
In this study, cytochrome P-450 and AHH activity were identified for the first 
time in brain  microsomal  suspensions from normal  animals.  The physiologic 
significance of the  small  amounts  of this  cytochrome present in brain  micro- 
somes would depend on several properties of the cytochrome in this tissue, such 
as  its  substrate  specificity,  inducibility,  and  distribution  within  the  central 
nervous system. Because brain microsomes contain large amounts of NADPH- 
cytochrome reductase (E.C. 1.6.2.4.,  [8]), the transfer of reducing equivalents to 
cytochrome P-450 would probably not be limiting for oxidative biotransforma- 
tions.  Localization  of cytochrome P-450 within  the central  nervous  system is 
likely,  although  not  examined  in  this  study.  Such  localization  is  strongly 
suggested by the recent observation of Fishman and associates that the mixed 
function oxidation of morphine occurs in vivo in specific areas of the brain only 
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Summary 
The difference spectra of the carbon monoxide-complex of dithionite-reduced 
rat brain microsomes, compared with both reduced microsomes, alone, and the 
carbon monoxide-complex of oxidized microsomes, indicate the presence of  small 
amounts of cytochrome P-450 in brain. As in liver, cytochrome P-450 in brain is 
degraded  in  vitro to  its  inactive  form,  cytochrome P-420,  by  methylmercury 
chloride. 
Aryl hydrocarbon hydroxylase activity is also present in rat brain microsomes 
and, at lower specific activity, in brain homogenates. This carcinogen metaboliz- 
ing activity is increased four-fold in rats pretreated with 3-methylcholanthrene. 
Received for publication 17 March 1977. 
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